APA (7th ed.) Citation

T, C., H, R., MJ, Y., CJ, F., D, J., JN, I., . . . PE, G. (2011). A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women. Breast cancer research and treatment, 126(2), 453. https://doi.org/10.1007/s10549-010-1322-0

Chicago Style (17th ed.) Citation

T, Cigler, et al. "A Randomized, Placebo-controlled Trial (NCIC CTG MAP.2) Examining the Effects of Exemestane on Mammographic Breast Density, Bone Density, Markers of Bone Metabolism and Serum Lipid Levels in Postmenopausal Women." Breast Cancer Research and Treatment 126, no. 2 (2011): 453. https://doi.org/10.1007/s10549-010-1322-0.

MLA (9th ed.) Citation

T, Cigler, et al. "A Randomized, Placebo-controlled Trial (NCIC CTG MAP.2) Examining the Effects of Exemestane on Mammographic Breast Density, Bone Density, Markers of Bone Metabolism and Serum Lipid Levels in Postmenopausal Women." Breast Cancer Research and Treatment, vol. 126, no. 2, 2011, p. 453, https://doi.org/10.1007/s10549-010-1322-0.